Vioxx Reps Will Shift To Vaccines In Second Half Of 2005
Merck expects to redeploy its Vioxx sales force to vaccines in the second half of 2005, the company said Dec. 14 during its annual business review in Whitehouse Station, N.J
Merck expects to redeploy its Vioxx sales force to vaccines in the second half of 2005, the company said Dec. 14 during its annual business review in Whitehouse Station, N.J